Role of peroxisome proliferator-activated receptorγ ligands in the vessel wall | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.03.2002 | Main Topics: Biotechnology In Vascular Surgery

Role of peroxisome proliferator-activated receptorγ ligands in the vessel wall

verfasst von: Alicja Jozkowicz, Ph.D., J. Dulak, J. Nanobashvili, M. Prager, I. Huk

Erschienen in: European Surgery | Ausgabe 2/2002

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Nitric oxide and carbon monoxide — Two gaseous regulators of vascular endothelial growth factor synthesis

Nächster Artikel Ciglitazone, ligand of peroxisome proliferator-activated receptor-γ, inhibits vascular endothelial growth factor activity

Titel: Role of peroxisome proliferator-activated receptorγ ligands in the vessel wall
verfasst von: Alicja Jozkowicz, Ph.D.
J. Dulak
J. Nanobashvili
M. Prager
I. Huk
Publikationsdatum: 01.03.2002
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 2/2002
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1046/j.1563-2563.2002.02032.x

Weitere Artikel der Ausgabe 2/2002

Invited commentary to: ‘Virtual dissection and automated polyp detection of the colon based on spiral CT — Techniques and preliminary experience on a cadaveric phantom’ (Eur. Surg. 2002;34:143–149)

Original Scientific Papers

α-Tocopherol pretreatment reduces ischaemia/reperfusion injury in rabbit skeletal muscle

Main Topics: Biotechnology In Vascular Surgery

Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischaemic limb muscles

Main Topics: Biotechnology In Vascular Surgery

Editorial

Main Topics: Biotechnology In Vascular Surgery

Closing remarks

Original Scientific Papers

Ischaemia/reperfusion injury of skeletal muscle: Mechanisms, morphology, treatment strategies, and clinical applications

Main Topics: Biotechnology In Vascular Surgery